Sanara MedTech
SMTI
21 hedge funds and large institutions have $7.79M invested in Sanara MedTech in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 3 closing their positions.
0.87% less ownership
Funds ownership: 4.48% → 3.61% (-0.87%)
9% less funds holding
Funds holding: 23 → 21 (-2)
23% less capital invested
Capital invested by funds: $10.2M → $7.79M (-$2.39M)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Rockefeller Capital Management
New York
|
+$25.4K |
| 2 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$24.6K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$18.5K |
| 4 |
State Street
Boston,
Massachusetts
|
+$15.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NRC
North Run Capital
Boston,
Massachusetts
|
-$1.04M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$269K |
| 3 |
LCM
Laurion Capital Management
New York
|
-$265K |
| 4 |
Morgan Stanley
New York
|
-$93.2K |
| 5 |
CC
Commons Capital
Needham,
Massachusetts
|
-$60K |
SMTI Hedge Fund Activity: Q1 2022 in Review
21 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q1 2022, worth a combined $7.79M — down 23% from $10.2M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SMTI and 1 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Rockefeller Capital Management, adding an estimated $25.4K. The largest seller was North Run Capital, cutting an estimated $1.04M.
- 21 institutional investors held Sanara MedTech (SMTI) as of Q1 2022, down from 23 in Q4 2021.
- Funds reported $7.79M of Sanara MedTech stock for Q1 2022, down 23% quarter-over-quarter.
- 1 fund opened new Sanara MedTech positions in Q1 2022 and 3 closed out, a net change of -2 holders.
- The largest Sanara MedTech buyer in Q1 2022 was Rockefeller Capital Management, an estimated $25.4K added.
- The largest Sanara MedTech seller in Q1 2022 was North Run Capital, an estimated $1.04M sold.
Based on aggregated 13F filings for Q1 2022.